2020 Scientific Retreat- Session 2

Session 2: Circulating DNA Methylation Biomarkers for Diagnosis, Prognosis and Treatment Selection 

8:10 AM – 9:10 AM 

Moderator:  
Gerhardt Attard, MD, PhD 
University College London Cancer Institute, UK 

Introduction 
Gerhardt Attard, MD, PhD 
University College London Cancer Institute, UK 

Using 5-hydroxymethylcytosine Sequencing to Interrogate Biological Drivers of Advanced Prostate Cancer 
Martin Sjöström, MD, PhD 
University of California, San Francisco 

Opportunities for Tracking the Prostate Cancer Methylome in Plasma 
Gerhardt Attard, MD, PhD 
University College London Cancer Institute, UK 

Circulating Methylation Biomarkers for Neuroendocrine Prostate Cancer Differentiation 
Francesca Demichelis, PhD 
University of Trento, Italy 

Live Session Discussion 

9:10 AM – 9:15 AM     Please Return to the Virtual Lobby to Join the Next Session